Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Melilla

6 clinical trials in Melilla, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Melilla at a glance
6
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

6 trials in Melilla

Open in trial search

Mite allergy

Recruiting

A study testing dust mite allergy extracts from Dermatophagoides pteronyssinus and Dermatophagoides farinae for patients with allergic rhinoconjunctivitis with or without controlled asthma

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:LETI Pharma S.L.U.

Study on the Safety and Effectiveness of Sovateltide for Patients with Acute Ischemic Stroke

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Sovateltide
  • Sponsor:Pharmazz EU Limited

Psychotic disorder+2

Recruiting

Study on ITI-1284 for Treating Psychosis in Alzheimer's Patients

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:ITI-1284
  • Sponsor:Intra-Cellular Therapies Inc.

Study on the Effectiveness and Safety of Mannan-Conjugated Allergoids for Treating Allergic Rhinitis/Rhinoconjunctivitis in Patients Allergic to House Dust Mites

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dermatophagoides pteronyssinus enriched allergoid, mannan-conjugated, polymerised
  • Sponsor:Inmunotek S.L.

Mite allergy

Not yet recruiting

Efficacy and safety of house dust mite allergoid (Dermatophagoides farinae, D. pteronyssinus, aluminium hydroxide) in people with moderate to severe house dust mite allergy

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Aluminium Hydroxide

Conjunctivitis allergic+3

Not recruiting

Study on the Effectiveness and Safety of Clustoid MM09 for Patients with Allergic Rhinitis or Rhinoconjunctivitis, with or without Mild to Moderate Asthma

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dermatophagoides Farinae Allergoid, Glutaraldehyde-Modified
  • Sponsor:Inmunotek S.L.

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Melilla

What the registry says about research in the country

01 Neurology

Research focusing on acute cerebral ischemic stroke treatment evaluation, examining innovative therapeutic approaches to improve patient outcomes. The trials aim to assess new interventions for better functional recovery in stroke patients.

  • Stroke Treatment
  • Neurological Recovery
  • Functional Outcomes

Studies emphasize assessment of patient recovery using standardized measurement scales.

02 Allergology & Respiratory Medicine

Clinical research exploring treatment options for allergic rhinitis and associated respiratory conditions. Trials evaluate new immunotherapy approaches for dust mite allergies.

  • Allergy Immunotherapy
  • Respiratory Health
  • Allergic Asthma Management

Investigation focuses on both preventive and therapeutic interventions for moderate to severe allergic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.